Instil Bio, Inc.

As of May 28, 2025, Instil Bio, Inc. shows a mildly bullish trend supported by strong weekly indicators and a positive monthly outlook, despite some short-term bearish signals from daily moving averages.

Instil Bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $28 million and a market cap of $182.69 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -33.34%.

As of Jun 18, Instil Bio, Inc. has a market capitalization of 182.69 million, with net sales of 0.00 million and a net profit of -78.03 million for the latest four quarters. Shareholder's funds are 169.44 million, and total assets are 264.76 million.